Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.
Finance & markets
Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
National Trade News capital-markets note (2026-11-09): Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity. Primary source: original at CNBC Top News (cnbc.com).